Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;88(3):e13596.
doi: 10.1111/aji.13596. Epub 2022 Jul 15.

Decreased severity of COVID-19 in vaccinated pregnant individuals during predominance of different SARS-CoV-2 variants

Affiliations

Decreased severity of COVID-19 in vaccinated pregnant individuals during predominance of different SARS-CoV-2 variants

Joe Eid et al. Am J Reprod Immunol. 2022 Sep.

Abstract

Problem: Since the start of the pandemic, Pregnant individuals have been disproportionately affected by the severe acute respiratory syndrome coronavirus 2. Vaccination has been shown to be protective against severe disease. However, data on effectiveness of vaccine in reducing disease severity are limited in pregnant individuals who later developed COVID-19.

Method of study: This is a single academic center retrospective cohort study of pregnant individuals who tested positive for COVID-19 from December 2020 through January 2022. The cohort was divided into two groups based on vaccination status. The primary outcome of our study was progression to severe or critical disease. A secondary analysis was performed based on the timeframes of predominance of different variants of SARS-CoV-2, to determine whether the effect of vaccination was different during these epochs.

Results: Our cohort included 472 patients among which 125 (26.5%) were vaccinated and 347 were unvaccinated. None of the patients in the vaccinated group who later developed COVID-19 progressed to severe or critical disease compared to 7.2% in the unvaccinated one (p < .01). Similarly, after adjusting for medical comorbidities, obesity, receipt of monoclonal antibodies, and trimester at diagnosis, vaccinated individuals who later developed COVID-19 were less likely to be admitted to the hospital (1.6% vs. 14.7%, aOR .14, 95% CI .22-.47) compared with unvaccinated ones.

Conclusion: Vaccination against SARS-CoV-2 in pregnant individuals who later develop a breakthrough infection, is associated with decreased progression to severe or critical COVID-19, and need for hospital and ICU admissions. Vaccination is specifically effective during the predominance of the more severe Delta variant.

Keywords: COVID-19; SARS-CoV-2 variants; pregnancy; vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest or financial disclosures.

Figures

FIGURE 1
FIGURE 1
COVID‐19 outcomes during different variants’ predominance timeframes

Similar articles

Cited by

References

    1. Cucinotta D, Vanelli M. WHO declares COVID‐19 a pandemic. Acta Biomed. 2020; 91(1):157‐160. 10.23750/abm.v91i1.9397 - DOI - PMC - PubMed
    1. Knight M, Bunch K, Vousden N, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS‐CoV‐2 infection in UK: national population based cohort study. BMJ. 2020; 369:m2107. 10.1136/bmj.m2107 - DOI - PMC - PubMed
    1. Metz TD, Clifton RG, Hughes BL, et al. Association of SARS‐CoV‐2 infection with serious maternal morbidity and mortality from obstetric complications. JAMA. 2022; 327(8):748‐759. 10.1001/jama.2022.1190 - DOI - PMC - PubMed
    1. DeBolt CA, Bianco A, Limaye MA, et al. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls. Am J Obstet Gynecol. 2021; 224(5):510.e1‐510.e12. 10.1016/j.ajog.2020.11.022 - DOI - PMC - PubMed
    1. Eid J, Abdelwahab M, Caplan M, et al. Increasing oxygen requirements and disease severity in pregnant individuals with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) delta variant. Am J Obstet Gynecol MFM. 2022;4(3):100612. 10.1016/j.ajogmf.2022.100612 - DOI - PMC - PubMed

Supplementary concepts